1. 09.01 Armoring anti-HER2 CAR-T cells with C-C-motive receptor 8 (CCR8) and a dominant negative TGF-b receptor (DNR) to enable efficacy in solid tumor models. (21st September 2022) Authors: Strzalkowski, TJ; Cadilha, BL; Dalloul, I; Manske, K; Endres, S; Kobold, S Journal: Journal for immunotherapy of cancer Issue: Volume 10(2022)Supplement 1 Page Start: A3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗